Embeda and Cva - a phase IV clinical study of FDA data

Summary:

Cva is reported as a side effect among people who take Embeda (morphine sulfate; naltrexone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Galafold, and have Pain.

The phase IV clinical study analyzes which people have Cva when taking Embeda. It is created by eHealthMe based on reports of 1,394 people who have side effects when taking Embeda from the FDA, and is updated regularly.

What is Embeda?

Embeda has active ingredients of morphine sulfate; naltrexone hydrochloride. eHealthMe is studying from 1,407 Embeda users. Check the latest studies of Embeda.

What is Cva?

Cva is found to be associated with 3,239 drugs and 3,018 conditions by eHealthMe. Check the latest studies of Cva.

On Jun, 23, 2026

1,394 people reported to have side effects when taking Embeda.
Among them, 15 people (1.08%) have Cva.

Among these 15 people:

How long have people been on Embeda when they have Cva? *

What is the gender of people who have Cva when taking Embeda? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Cva when taking Embeda? *

What are other drugs people take besides Embeda? *

What are other side effects people have besides Cva? *

Flatulence (flatus expelled through the anus): 7 people, 46.67%
Adverse Event: 7 people, 46.67%
Impaired Work Ability: 7 people, 46.67%
Fainting (loss of consciousness and postural tone): 7 people, 46.67%
Rhinorrhea (watery mucus discharge from the nose): 7 people, 46.67%
Device Related Infection: 7 people, 46.67%
Pain: 7 people, 46.67%
Loss Of Consciousness: 7 people, 46.67%
Depression: 7 people, 46.67%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 6 people, 40.00%

What are the existing conditions these people have? *

Pain: 11 people, 73.33%
Heart Disease: 7 people, 46.67%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 7 people, 46.67%
Depression: 5 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 2 people, 13.33%
Stable Angina (a constant chest pain): 1 person, 6.67%
Neuralgia (pain in one or more nerves): 1 person, 6.67%
Neck Pain: 1 person, 6.67%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 6.67%
Diabetes: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Embeda and have Cva?

- Check whether Cva is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embeda:

Embeda (1,407 reports)

Cva treatments and more:

Cva (334,635 reports)

How severe was Cva and when was it recovered:

Cva in Embeda

Expand to all the drugs that have ingredients of morphine sulfate; naltrexone hydrochloride:

Cva and drugs with ingredients of morphine sulfate; naltrexone hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embeda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cva:

Cva (3,239 drugs)

Browse all the conditions that are associated with Cva:

Cva (3,018 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate; naltrexone hydrochloride (the active ingredients of Embeda) and Embeda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.